SEAMILD FOODS(002956)2024-04-25 11:53Financial Performance - The company's revenue for Q1 2024 reached ¥565,623,157.32, representing a 46.07% increase compared to ¥387,216,955.86 in the same period last year[4] - Net profit attributable to shareholders was ¥45,003,373.32, up 14.59% from ¥39,274,078.36 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥41,841,352.56, reflecting a 21.74% increase from ¥34,369,626.64 in the previous year[4] - Basic earnings per share rose to ¥0.2013, a 13.79% increase from ¥0.1769 in the previous year[4] - Operating profit for Q1 2024 was CNY 53,609,368.29, up from CNY 49,090,972.07 in the same period last year, indicating a growth of 5.1%[19] - The total comprehensive income for Q1 2024 was CNY 45,003,373.32, consistent with the net profit figure[19] Cash Flow and Assets - The net cash flow from operating activities increased by 33.65% to ¥55,129,129.89, compared to ¥41,249,114.77 in the same quarter last year[4] - The company's cash and cash equivalents decreased from 526,227,810.28 yuan to 442,720,370.71 yuan, a decline of approximately 15.8%[14] - The company reported cash and cash equivalents at the end of Q1 2024 amounting to CNY 402,603,878.11, down from CNY 459,409,907.10 at the end of Q1 2023[22] - The total assets at the end of the reporting period were ¥1,910,954,583.15, down 4.93% from ¥2,010,154,161.58 at the end of the previous year[4] - The company's total assets decreased from 2,010,154,161.58 yuan at the beginning of the period to 1,910,954,583.15 yuan at the end of the period, a reduction of approximately 4.94%[16] Investment and Expenses - The total investment for the "Ximai Health Food Project" is planned at 330 million yuan, with at least 200 million yuan allocated for fixed asset investment[12] - The first phase of investment is set at 152 million yuan, with 145 million yuan for fixed assets, utilizing the ongoing "Jiangsu Ximai Oat Food Innovation Factory Project" as part of this investment[12] - Research and development expenses for the quarter were 1,784,195.50 yuan, compared to 1,536,385.95 yuan in the previous year, reflecting a growth of about 16%[17] - Total operating costs increased to 517,647,980.46 yuan, up from 345,014,118.42 yuan, marking a rise of approximately 50%[17] Liabilities and Equity - Total liabilities decreased from 551,404,156.83 yuan to 416,048,027.65 yuan, representing a decline of about 24.6%[16] - Shareholders' equity attributable to shareholders increased by 2.48% to ¥1,494,906,555.50 from ¥1,458,750,004.75 at the end of the previous year[4] Revenue Growth Factors - The company attributed the revenue growth to a focus on a big product strategy and collaborative innovation in products and channels[7] - Total revenue from operating activities reached CNY 528,594,555.05, compared to CNY 389,207,922.93 in Q1 2023, marking a significant increase of 35.9%[21] Non-Recurring Gains - Non-recurring gains totaled ¥3,162,020.76, primarily from government subsidies and other income[5] - The company does not have any other non-recurring gains or losses that meet the definition of non-recurring items[6] Market Expansion - The company plans to establish a wholly-owned subsidiary in Suqian Economic and Technological Development Zone, further expanding its market presence[12] Other Information - The gross profit margin for the quarter is approximately 8.5%, calculated from the difference between operating revenue and operating costs[17] - The company experienced a foreign exchange impact on cash and cash equivalents amounting to CNY 68,373.87 in Q1 2024[21] - The company did not report any new product launches or significant market expansion strategies during this quarter[19]